April 02, 2020
Oncopeptides strengthens its corporate communications function by appointing Rolf Gulliksen as Global Head of Corporate Communications
Media
April 01, 2020
Nordic Nanovector Announces Focus on Advancing PARADIGME and Actions to Extend Cash Runway into 2021
March 31, 2020
Vicore Pharma submits Letter of Intent for a clinical trial application for a phase II study in patients with COVID-19, SARS CoV-2 infection
March 30, 2020
Vicore submits clinical trial application for phase II trial with C21 in IPF 2020-03-30
March 27, 2020
Nordic Nanovector ASA publishes 2019 Annual Report
March 26, 2020
Orexo publishes the Annual Report for 2019
March 26, 2020
Oncopeptides announces 26% Overall Response Rate of melflufen in triple-class refractory multiple myeloma patients from the pivotal HORIZON study
March 26, 2020
Aprea Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
March 25, 2020
Orexo has repurchased 14 percent of own corporate bonds
March 24, 2020
The Lancet Haematology Publishes Results from Oncopeptides’ Multicenter, International Phase 1/2 Study (O-12-M1)